Print Friendly, PDF & Email

NCT/Study#

NCT03584516 /

INCB-39110-309

GRAVITAS-309: A Phase 2/3 Study of Itacitinib and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease

DISEASE GROUP:

Transplant

current phase:

Phase II/III

STUDY STATUS:

Accepting Patients

Location:

Hackensack, NJ

For More information:

Call 201-518-3587